February 18, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Conexiant

February 18, 2026

Creatinine Index Linked to CKD Mortality

Prospective UK cohort study links higher creatinine muscle index to lower odds of probable sarcopenia and reduced pre–kidney replacement therapy mortality.

Conexiant

February 18, 2026

Weight Regain Rapidly Follows GLP-1 Cessation

Systematic review finds most lost weight returns within two years of stopping weight management medication

Conexiant

February 17, 2026

CKD Markers Linked to Cognitive Risk

In adults with chronic kidney disease, higher proteinuria and lower estimated glomerular filtration rate are associated with increased risk of incident cognitive impairment.

Conexiant

February 17, 2026

Corneal Imaging and an ‘Overlooked Source’

Investigators evaluate how iris pigmentation influences Scheimpflug-derived corneal densitometry measurements.

Conexiant

February 17, 2026

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Conexiant

February 16, 2026

Metformin and AMD: Signal or Noise?

Five-year population study details 37% lower incidence of intermediate AMD in type 2 diabetic patients prescribed metformin

Conexiant

February 16, 2026

Intermittent Fasting Shows No Edge Over Standard Diets

Cochrane review finds the approach produces similar weight loss and quality-of-life outcomes compared with conventional calorie restriction

Conexiant

February 13, 2026

Primary Care’s Rug Pulled Out?

CMS abruptly scraps a 10-year primary care model, leaving nearly 700 practices rethinking staffing, funding, and patient access.

KFF Health News